Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Vertex Pharmaceuticals Inc. buy Barclays PLC

Vertex Pharmaceuticals Inc.
Start price
€327.60
11.12.23 / 50%
Target price
€385.41
11.12.24
Performance (%)
35.84%
End price
€445.00
12.12.24
Summary
This prediction ended on 12.12.24 with a price of €445.00. The BUY prediction by Barclays_PLC for Vertex Pharmaceuticals Inc. saw massive gains of 35.84%. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Vertex Pharmaceuticals Inc. 4.754% 4.754% -10.555%
iShares Core DAX® 0.760% 1.149% 17.258%
iShares Nasdaq 100 0.732% 1.884% 8.152%
iShares Nikkei 225® 1.025% -0.865% 13.066%
iShares S&P 500 -0.036% 1.480% 3.393%

Comments by Barclays_PLC for this prediction

In the thread Trading Vertex Pharmaceuticals Inc.
Prediction Buy
Perf. (%) 35.84%
Target price 385.411
Change
Ends at 11.12.24

Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten

Barclays PLC 
0
Report Share
12.12.24
In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 35.84%
Target price 385.411
Change
Ends at 11.12.24

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Barclays PLC from $408.00 to $415.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat

Barclays PLC 
0
Report Share
11.12.23

Stopped prediction by Barclays_PLC for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€387.70
06.02.24
€439.24
06.02.25
19.98%
07.02.25

Barclays PLC 
06.02.24 50%